NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-179-2018-0-PC-01 Remodelins, A New Class Of Compounds To Prevent Or Treat Cancer Metastasis Or Glaucoma PCT PCT PCT/US2020/026383 Expired
NCATS E-120-2018-0-PC-01 REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS PCT PCT PCT/US2020/026371 Expired
NCATS E-120-2018-0-EP-01 REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS EP National Stage 20783111.6 Pending
NCI E-182-2017-0-JP-08 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION JP National Stage 2020-519092 Pending
NCI E-182-2017-0-US-11 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION US National Stage 16/652,948 12227554 Issued PDF
NIAID E-233-2017-0-US-05 ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES US National Stage 16/652,804 11313867 Issued PDF
NCI E-233-2014-0-JP-08 METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2020-066108 Abandoned
NCI E-182-2017-0-IL-07 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION IL National Stage 273698 Issued
NEI E-192-2014-1-AU-09 Surgical Tool and Method for Ocular Tissue Transplantation AU DIV 2020202248 Issued
NCI E-053-2015-1-US-10 MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE US DIV 16/835,102 11014902 Issued PDF
NCI E-146-2018-0-US-03 METHOD FOR TREATING GLIOBLASTOMA US National Stage 16/652,230 Abandoned
NIDCR E-047-2020-0-US-01 METHOD FOR BLOCKING UPTAKE OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED RADIONUCLIDES BY EXOCRINE ORGANS US 63/001,681 Abandoned
NIBIB E-006-2020-0-US-01 SYSTEMS AND METHODS FOR MULTIVIEW SUPER-RESOLUTION MICROSCOPY US 63/001,691 Abandoned
NIAID E-182-2020-2-US-01 CORONAVIRUS RNA VACCINES US 63/002,094 Abandoned
NIBIB E-006-2020-1-US-01 SYSTEMS AND METHODS FOR OPTICAL REASSIGNMENT IN MULTIVIEW SUPER-RESOLUTION MICROSCOPY US 63/001,672 Abandoned
NCI E-237-2017-2-NZ-14 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ National Stage 763023 Pending
NIAID E-097-2020-0-JP-08 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE JP National Stage 2022-557764 Issued
NCI E-237-2017-2-US-16 T CELL RECEPTORS RECOGNIZING MUTATED P53 US National Stage 16/651,242 11939365 Issued PDF
NCI E-237-2017-1-JP-08 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION JP National Stage 2020-517553 Issued
NIAID E-097-2020-0-PCT-01 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE PCT PCT PCT/US2020/024985 Expired
NIAID E-097-2020-0-EP-06 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE EP National Stage 20719313.7 Pending
NCI E-133-2017-0-EP-03 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS EP National Stage 18783234.0 Pending
NCATS E-157-2020-0-US-01 METHODS OF TREATING CORONAVIRUS INFECTIONS US 63/000,425 Abandoned
NIAID E-097-2020-0-CA-05 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE CA National Stage 3174779 Pending
NIAID E-097-2020-0-BR-04 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE BR National Stage BR112022017512-4 Pending
NIAID E-097-2020-0-AU-03 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE AU National Stage 2020437669 Pending
NIAID E-097-2020-0-IN-07 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE IN National Stage 202217058054 Pending
NCI E-237-2017-1-US-11 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION US National Stage 16/650,696 Pending
NHLBI E-196-2017-0-US-03 POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS US National Stage 16/650,507 Abandoned
NCI E-237-2017-1-IL-07 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION IL National Stage 273516 Issued
NCI E-237-2017-2-IL-09 T CELL RECEPTORS RECOGNIZING MUTATED P53 IL National Stage 273515 Pending
NCATS E-232-2017-0-KR-11 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders KR National Stage 10-2020-7008731 Pending
NCI E-181-2017-0-NZ-19 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS NZ National Stage 762831 Pending
NCI E-061-2020-0-US-01 METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US 62/992,701 Abandoned
NCI E-102-2020-0-US-01 METHODS OF ISOLATING T CELLS AND T-CELL RECEPTORS FROM PERIPHERAL BLOOD BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY US 62/992,715 Abandoned
NCI E-084-2019-0-CN-06 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand CN National Stage 202080023309.6 Issued
NCI E-084-2019-0-PCT-02 AUTOMATIC SYSTEM AND METHOD FOR TISSUE SECTIONING, STAINING, AND SCANNING PCT PCT PCT/US2020/023644 Expired
NCI E-084-2019-0-EP-03 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand EP National Stage 20772823.9 Pending
NCI E-231-2017-0-US-03 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN US National Stage 16/648,369 11795235 Issued PDF
NCI E-133-2017-0-JP-04 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS JP National Stage 2020-516436 Issued
NCI E-104-2013-0-US-05 ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 16/823,218 11512138 Issued PDF
NCI E-133-2017-0-US-05 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS US National Stage 16/648,008 11898166 Issued PDF
NCI E-099-2014-0-US-12 USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US DIV 16/821,674 11702472 Issued PDF
NCI E-234-2014-1-KR-01 B T METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF KR DIV 10-2020-7007771 Abandoned
NIDDK E-101-2020-0-US-01 ANTIBACTERIAL AND ANTIFUNGAL POLYKETIDES FROM ENVIRONMENTAL AMYCOLATOPSIS SPP US 62/990,557 Expired
NCI E-013-2018-0-JP-08 Fully Human Antibody Targeting Human CD19 For Cancer Therapeutic Development JP National Stage 2020-515262 Issued
NCI E-210-2018-0-PCT-02 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY PCT PCT PCT/US2020/022752 Expired
NIAID E-095-2019-0-PCT-02 HIV RNA VACCINES PCT PCT PCT/US2020/022710 Expired
NCI E-210-2018-0-HK-05 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY HK EP 62022051308.4 Pending
NCI E-210-2018-0-CN-04 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY CN National Stage 202080021582.5 Pending